Stocks
Amylyx Pharmaceuticals (AMLX) EV/EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | 10.6 | 0.29 | 1.16 | -10.5 | 15.6 | 1.09 | ||
| Changes by years, y/y, % | -97% | +296% | -1 006% | -248% | +10.1% | ||||
Amylyx Pharmaceuticals. EV/EBITDA
Amylyx Pharmaceuticals. EV/EBITDA, changes, %
Amylyx Pharmaceuticals (AMLX) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EV/EBITDA | ? | -123.8 | 15.8 | 2.21 | 1.15 | 0.05 | 1.09 | |
| Changes by years, y/y, % | +1 927% | -253% | -121% | -108% | -100% | |||
| Changes by quarters, q/q, % | +809% | -113% | -86% | -48% | -95% | |||
